PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+20.77%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$707M
AUM Growth
+$707M
(+30%)
Cap. Flow
+$87.9M
Cap. Flow
% of AUM
12.44%
Top 10 Holdings %
Top 10 Hldgs %
36.4%
Holding
113
New
10
Increased
54
Reduced
24
Closed
24
Top Buys
| 1 |
Abbott
ABT
|
$17.3M |
| 2 |
Inspire Medical Systems
INSP
|
$15.6M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$13.3M |
| 4 |
Amgen
AMGN
|
$12M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
$11.4M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$13.8M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$11.4M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$8.68M |
| 4 |
Charles River Laboratories
CRL
|
$8.65M |
| 5 |
Zimmer Biomet
ZBH
|
$7.97M |
Sector Composition
| 1 | Healthcare | 99.16% |
| 2 | Industrials | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Day One Biopharmaceuticals
DAWN
$766M
| $9.14M | 1.29% |
625,749
+159,341
| +34% | +$2.33M |
|
27
Mettler-Toledo International
MTD
$26.1B
| $9.1M | 1.28% |
+7,500
| New | +$9.1M |
|
28
MannKind Corp
MNKD
$1.69B
| $9.09M | 1.28% |
2,498,624
+429,677
| +21% | +$1.56M |
|
|
DCPH
29
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $9.05M | 1.27% |
561,025
-36,378
| -6% | -$587K |
|
30
Humana
HUM
$37.5B
| $8.28M | 1.17% |
18,081
-3,230
| -15% | -$1.48M |
|
31
Castle Biosciences
CSTL
$673M
| $7.71M | 1.09% |
357,156
+132,564
| +59% | +$2.86M |
|
32
CVRx
CVRX
$204M
| $7.55M | 1.06% |
240,000
+17,880
| +8% | +$562K |
|
33
Edgewise Therapeutics
EWTX
$1.54B
| $7.13M | 1% |
651,625
+178,313
| +38% | +$1.95M |
|
34
Arvinas
ARVN
$580M
| $6.87M | 0.97% |
167,001
+62,884
| +60% | +$2.59M |
|
|
SILK
35
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $6.69M | 0.94% |
545,235
+295,894
| +119% | +$3.63M |
|
36
Veracyte
VCYT
$2.41B
| $6.53M | 0.92% |
237,316
+11,444
| +5% | +$315K |
|
37
Haemonetics
HAE
$2.57B
| $5.98M | 0.84% |
69,940
-19,022
| -21% | -$1.63M |
|
|
AUGX
38
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $5.94M | 0.84% |
1,015,814
+639,732
| +170% | +$3.74M |
|
|
BCYC
39
Bicycle Therapeutics
BCYC
$492M
| $5.66M | 0.8% |
312,889
+190,168
| +155% | +$3.44M |
|
40
Cullinan Oncology
CGEM
$456M
| $5.4M | 0.76% |
529,877
+91,132
| +21% | +$929K |
|
41
Disc Medicine
IRON
$2.14B
| $5.36M | 0.76% |
92,871
+40,813
| +78% | +$2.36M |
|
42
Thermo Fisher Scientific
TMO
$183B
| $5.31M | 0.75% |
10,000
-5,332
| -35% | -$2.83M |
|
43
Sutro Biopharma
STRO
$85.6M
| $5.16M | 0.73% |
1,202,431
+20,263
| +2% | +$86.9K |
|
44
Bristol-Myers Squibb
BMY
$96.7B
| $5.13M | 0.72% |
+100,000
| New | +$5.13M |
|
45
Lantheus
LNTH
$3.75B
| $4.96M | 0.7% |
80,000
+30,111
| +60% | +$1.87M |
|
46
MoonLake Immunotherapeutics
MLTX
$3.78B
| $4.95M | 0.7% |
82,009
+28,716
| +54% | +$1.73M |
|
|
PHLT
47
Performant Healthcare, Inc. Common Stock
PHLT
$602M
| $4.94M | 0.7% |
1,580,865
+281,480
| +22% | +$880K |
|
48
Arcus Biosciences
RCUS
$1.24B
| $4.73M | 0.67% |
247,664
+42,555
| +21% | +$813K |
|
49
Insmed
INSM
$30.3B
| $4.67M | 0.66% |
150,816
+25,816
| +21% | +$800K |
|
50
IDEAYA Biosciences
IDYA
$2.26B
| $4.63M | 0.65% |
130,265
-2,436
| -2% | -$86.7K |
|